American tegumentary leishmaniasis caused by Leishmania (Viannia) braziliensis: assessment of parasite genetic variability at intra- and inter-patient levels

Table 1 Clinical and epidemiological characteristics of the 35 patients analysed in this study

Patient code	Age (years)	Sex	Clinical form	Location of lesion/Code
				Cutaneous	Mucosal
1	52	M	MCL	Arm/1MCL-C	Oral / 1MCL-O
2	48	M	MCL	Nostril/2MCL-C	Oral/2MCL-O
3	25	M	MCL	Arm/3MCL-C	Nasal/3MCL-N
4	54	M	MCL	ND	Oral/4MCL-O
5	47	M	MCL	Arm/5MCL-C	Nasal/5MCL-N
5	47	M	MCL	Arm/5MCL-C	Oral/5MCL-O
6	16	M	MCL	ND	Nasal/6MCL-N
7	50	M	MCL	Face/7MCL-C	Nasal/7MCL-N
8	29	M	MCL	Trunk/8LMC-C	Nasal/8MCL-N
9	55	M	MCL	ND	Oral/9MCL-O
10	42	M	MCL	ND	Nasal/10MCL-N
11	52	F	MCL	Arm/11MCL-C	Nasal/11MCL-N
12	25	M	MCL	Trunk/12MCL-C	Oral/12MCL-O
13	52	F	MCL	ND	Oral/13MCL-O
14	54	M	MCL	Upper lip/14MCL-C	Nasal/14MCL-N
15	69	M	MCL	ND	Nasal/15MCL-N
16	65	M	MCL	ND	Oral/16MCL-O
17	63	F	ML	A	Nasal/17ML-N
18	53	M	ML	A	Nasal/18ML-N
19	66	F	ML	A	Nasal/19ML-N
20	71	M	ML	A	Nasal/20ML-N
21	12	M	ML	A	Nasal/21ML-N
22*	49	F	ML	A	Nasal/22ML-N
23*	69	M	ML	A	Nasal/23ML-N
24*	60	M	ML	A	Nasal/24ML-N
25*	77	M	ML	A	Nasal/25ML-N
26*	72	M	ML	A	Nasal/26ML-N
27*	71	F	ML	A	Nasal/27ML-N
28*	39	M	ML	A	Nasal/28ML-N
29*	63	M	ML	A	Nasal/29ML-N
30*	44	F	ML	A	Nasal/30ML-N
31*	31	F	ML	A	Nasal/31ML-N1
31*	31	F	ML	A	Nasal/31ML-N2
32*	29	F	ML	A	Nasal/32ML-N1
32*	29	F	ML	A	Nasal/32ML-N2
33*	72	F	ML	A	Oral/33LM-O
34	49	M	DL	Arm/ 34DL-C1	Nasal/34DL-N
				Trunk/34DL-C2
				Leg/34DL-C3
35	41	M	DL	Nose/35DL-C	Nasal/35DL-N
					Oral/35DL-O

*, Patients reporting the absence of an initial cutaneous lesion or scar suggestive of leishmaniasis; M male, F female, MCL, mucocutaneous leishmaniasis, ML mucosal leishmaniasis, DL disseminated leishmaniasis, ND not done, A absence of cutaneous lesion at the time of clinical evaluation.

ISSN: 1756-3305